Shares of Eli Lilly and Company (NYSE:LLY) climbed +0.10% and ended at $78.59 greater than previous closing price of $78.51. The total 2.97 million shares were bought and sold throughout the most recent trading session less than average volume of 3.84 million shares.
Eli Lilly and Company (LLY):
Currently Eli Lilly and Company (LLY) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “15″ Analysts”. “0” rated “Sell” for the company. “6” said the company as a “Hold”. Overweight rating was given by “2” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $97.71 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $116.00 however minimum price target advised by analysts is $77.00. The Median price target for the stock is measured at $99.00.
Presently, Analysts decided consensus EPS estimate of $0.95 for present quarter and one month ago projected EPS estimate was at $0.95. If we take a look at back 3 month ago, consensus EPS estimate was $0.94.
A current consensus EPS estimate for next quarter is at $0.94 and 3 month ago EPS forecast was $0.95. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.94.
For current fiscal year, most recent EPS estimate is set at $3.58 based on Analyst consensus and three month ago consensus EPS opinions was at $3.57. During period one month ago, consensus EPS forecast was decided at $3.58.
A current consensus EPS projection for next fiscal year is observed at $4.09 and one month ago consensus EPS forecast was at $4.09. Take a look at back three month ago, consensus EPS estimate opinions was decided at $3.95 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 15 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 2. 6 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 15 said a “Buy Rating” and 2 announced “Overweight Rating”. 7 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.